1) CDA-Ⅱ
尿多酸肽(CDA-Ⅱ)
1.
The Foundational Studies of Anticancer Active Substance in CDA-Ⅱ;
尿多酸肽（CDA-Ⅱ）中抗肿瘤活性的物质基础研究
2) Uroacitides(CDA-II)
尿多酸肽(CDA-II)
3) CDA-2
尿多酸肽
1.
CDA-2 Induces the Demethylation of p~(15INK4B) Gene in High-risk Myelodysplastic Syndrome Cells;
尿多酸肽对高危组骨髓增生异常综合征细胞株p15~(INK4B)基因的去甲基化作用
2.
Objective: To study the effect of Uroacitide (CDA-2) on the proliferation, differentiation and autocrine of human endometrial carcinoma cell line EAC.
目的:研究尿多酸肽(CDA-2)对EAC人子宫内膜癌细胞增殖、分化及细胞自分泌的影响。
3.
To study the change and significance of nestin expression in differentiation of SWO-38 human glioma cells induced by CDA-2 (Uroacitide),a healthy human urine extraction.
目的:研究巢蛋白(nestin)与人胶质瘤恶性程度之间的相关性;研究SWO-38人胶质瘤细胞在多分子靶点诱导分化剂尿多酸肽(CDA-2)诱导前后nestin表达的变化及其意义。
4) Uroacitide
尿多酸肽
1.
Determination of 4-Hydroxybenzene-acetic acid and 5-hydroxyindol acetic acid in Uroacitide Injection by HPLC;
HPLC法同时测定尿多酸肽注射液中4-羟基苯乙酸及5-羟基吲哚乙酸的含量
2.
Uroacitide from Human Urine Against Human Liver Cancer Cell Smmu 7721 in vitro and in vivo;
尿多酸肽对人肝癌细胞Smmu7721体内体外抑制作用
3.
Objective:To study the inhibitory effect of Uroacitide(CDA-II) on human gastric cancer cell in vitro.
目的:研究肿瘤细胞分化诱导剂尿多酸肽(CDA-II)对人胃癌细胞的体外抑制作用。
5) uroacitides
尿多酸肽
1.
Effect of uroacitides injection on the function of the helper T1 lymphocytes in the secretion of interleukin-2 and interferon-γ in vitro;
尿多酸肽对外周血Th1淋巴细胞分泌白细胞介素-2和干扰素-γ的影响
2.
Phase I clinical trial and tolerance study of uroacitides;
尿多酸肽注射液I期临床耐受性研究
6) hyperuricuria
[,haipə,rjuəri'kjuəriə]
尿尿酸过多
补充资料：肾性葡萄糖尿氨基酸尿磷酸盐尿症
肾性葡萄糖尿氨基酸尿磷酸盐尿症
renal glucosuria aminoaciduria and phosphaturia
又称“Fanconi综合征”。遗传性或获得性近端肾小管多种功能异常疾病。临床上表现为肾性糖尿、全氨基酸尿、磷酸盐尿、高血氯性代谢性酸中毒、低血钾、多尿及肾小管性蛋白尿等。遗传性Fanconi综合征又可分为成人型及婴儿型两类，后者又称为“de-Toni-Debre-Fanconi综合征”或“Lignac-Fonconi综合征”。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条